Skip to main content

JPMORGAN CHASE & CO

Position in CHRS — Coherus Oncology, Inc.

CIK 19617 NEW YORK, NY

Position in CHRS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$92,492
+$2,659 QoQ
Shares Held
66,066
+24.3% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 18% Shared 0% None 82%

Common Shares in CHRS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. CHRS ranks #274 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CHRS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $92,492 66,066
2026-03-31 $89,833 53,156
2025-12-31 $72,640 51,156
2025-09-30 $176,464 107,601
2025-06-30 $74,400 101,780
2025-03-31 $180,060 223,125
2024-12-31 $68,641 49,741
2024-09-30 $63,837 61,383
2024-06-30 $104,335 60,310
2024-03-31 $542,718 227,079
2023-12-31 $1,450,766 435,666
2023-09-30 $20,121,976 5,380,208
2023-06-30 $24,462,477 5,728,918
2023-03-31 $40,920,536 5,982,535
2022-12-31 $51,516,179 6,504,863
2022-09-30 $58,863,601 6,125,245
2022-06-30 $46,960,310 6,486,231
2022-03-31 $84,890,257 6,575,543
2021-12-31 $106,768,375 6,689,748
2021-09-30 $115,235,830 7,170,867
2021-06-30 $84,280,819 6,094,058
2021-03-31 $75,915,107 5,196,106
2020-12-31 $86,093,254 4,953,582
2020-09-30 $86,754,746 4,730,357
2020-06-30 $81,046,963 4,537,904
2020-03-31 $66,895,251 4,124,245